We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock Outlines Important Research Takeaways from COVID-19 Pandemic
Woodcock Outlines Important Research Takeaways from COVID-19 Pandemic
Research into COVID-19 therapeutics has faced a number of problems during the pandemic that ought to be learned from, including underpowered trials, a lack of coordination and enrollment issues, according to Center for Drug Evaluation and Research (CDER) Director Janet Woodcock, who is currently on leave heading the therapeutics arm of the government’s Operation Warp Speed program.